Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(+)-FTCMP + H2O
?
-
-
-
-
?
2',2'-difluoro-dCMP + H2O
2',2'-difluoro-dUMP + NH3
-
-
-
-
?
2',3'-dideoxy-5-fluoro-3'-thiacytidine + H2O
?
-
good substrate
-
-
?
5-aza-dCMP + H2O
5-aza-dUMP + NH3
-
-
-
-
?
5-Hg-dCMP + H2O
5-Hg-dUMP + NH3
5-hydroxymethyl-dCMP + H2O
5-hydroxymethyl-dUMP + NH3
-
HeLa cells, good substrate
-
-
?
5-methyl-dCMP + H2O
5-methyl-dUMP + NH3
5-methyl-dCMP + H2O
dTMP + NH3
ara-CMP + H2O
ara-UMP + NH3
beta-D-2',2'-difluorodeoxycytidine + H2O
beta-D-2',2'-difluorodeoxyuridine + NH3
-
-
-
-
?
PSI-6130-MP + H2O
?
-
weak substrate
-
-
?
additional information
?
-
5-Hg-dCMP + H2O
5-Hg-dUMP + NH3
-
very poor substrate in the absence of mercaptoethanol
-
-
?
5-Hg-dCMP + H2O
5-Hg-dUMP + NH3
-
deamination activated by dTTP and inhibited by dCTP
-
-
?
5-Hg-dCMP + H2O
5-Hg-dUMP + NH3
-
5-mercury derivative of dCMP only in the presence of an excess of mercaptoethanol
-
-
?
5-methyl-dCMP + H2O
5-methyl-dUMP + NH3
-
-
-
-
?
5-methyl-dCMP + H2O
5-methyl-dUMP + NH3
-
HeLa cells, good substrate
-
-
?
5-methyl-dCMP + H2O
dTMP + NH3
-
-
-
-
?
5-methyl-dCMP + H2O
dTMP + NH3
-
deamination pathway, overview
-
-
?
ara-CMP + H2O
ara-UMP + NH3
-
arabinosyl-CMP
-
-
?
ara-CMP + H2O
ara-UMP + NH3
-
1-beta-D-arabinofuranosyl-CMP
-
-
?
ara-CMP + H2O
ara-UMP + NH3
-
effective substrate in presence of dCTP
-
-
?
ara-CMP + H2O
ara-UMP + NH3
-
fair substrate
-
-
?
CMP + H2O
UMP + NH3
-
poor substrate
-
-
?
CMP + H2O
UMP + NH3
-
HeLa cells, at 1 mM, in presence and absence of dCTP and Mg2+: not a substrate
-
-
?
dCMP + H2O
dUMP + NH3
-
-
-
?
dCMP + H2O
dUMP + NH3
-
-
-
?
dCMP + H2O
dUMP + NH3
-
-
-
?
dCMP + H2O
dUMP + NH3
-
-
-
?
dCMP + H2O
dUMP + NH3
-
-
-
-
?
dCMP + H2O
dUMP + NH3
-
most dramatic allosteric response at substrate levels 0.1 mM dCMP or less
-
?
dCMP + H2O
dUMP + NH3
-
high degree of specificity of dCMP
-
ir
dCMP + H2O
dUMP + NH3
-
enzyme contributes formation of DNA by providing dUMP as substrate for thymidylate synthase. Potential role in cell division
-
?
dCMP + H2O
dUMP + NH3
-
providing an adequate supply of dUMP for formation of dTMP, via dTMP synthase a crucial intermediate for synthesis of DNA
-
-
?
dCMP + H2O
dUMP + NH3
-
key enzyme in pyrimidine deoxyribonucleotide metabolism, catalyzing the rate-limiting step, plays an important role in providing a balanced supply of dCTP and dTTP for DNA synthesis
-
?
dCMP + H2O
dUMP + NH3
-
important role in regulation of intracellular TTP levels
-
-
ir
dCMP + H2O
dUMP + NH3
-
importance in the generation of dUMP, precursor for synthesis of thymidine nucleotides
-
-
?
dCMP + H2O
dUMP + NH3
-
enzyme is major source of mammalian cell dUMP pool and regulates the synthesis of TMP
-
-
ir
dCMP + H2O
dUMP + NH3
-
the enzyme is important in the de novo synthesis of thymidine nucleotides, and may also be involved in the metabolism of anticancer agents
-
-
?
dCMP + H2O
dUMP + NH3
-
the enzyme plays a key role in the thymidylate synthase, pathway overview
-
-
?
additional information
?
-
-
-
-
-
?
additional information
?
-
-
substrate specificity
-
-
?
additional information
?
-
-
substrate specificity
-
-
?
additional information
?
-
-
substrate specificity
-
-
?
additional information
?
-
-
HeLa cells, no activity with CDP at 1 mM, in presence and absence of dCTP and Mg2+
-
-
?
additional information
?
-
-
enzyme is involved in elimination of some dCyd analogues, such as 2',2'-difluorodeoxycytidine, fluoro-dCyd, and ara-C, from tissues or cultured cells
-
-
?
additional information
?
-
-
the enzyme also performs 5-methylcytidyl-DNA deaminase activity but to a lesser extent, deamination pathway, overview
-
-
?
additional information
?
-
-
the human cytomegalovirus requires the cellular host dCMP deaminase for replication in quiescent cells, overview
-
-
?
additional information
?
-
-
substrate specificity with deoxycytidine analogue monophosphates, overview
-
-
?
additional information
?
-
-
the enzyme also performs 5-methylcytidyl-DNA deaminase activity but to a lesser extent, substrate specificity, overview
-
-
?
additional information
?
-
-
cytidine monophosphate is not a good substrate for dCMPD. Monophosphates of deoxycytidine analogs nucleosides in the L-conformation (e.g. apricitabine, lamivudine, and emtricitabine) and dideoxycytidine do not act as substrates of dCMPD
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Co2+
-
divalent cations not necessary to improve activity, activation by dCTP and inhibition by dTTP both show an absolute requirement for a divalent cation. Mg2+, Ca2+ and Mn2+ almost equally effective in promoting activation by dCTP, Cu2+, Zn2+, and Co2+ are ineffective
divalent cations
-
divalent cations not necessary to improve activity, activation by dCTP and inhibition by dTTP both show an absolute requirement for a divalent cation. Mg2+, Ca2+ and Mn2+ almost equally effective in promoting activation by dCTP, Cu2+, Zn2+, and Co2+ are ineffective
Zn2+
-
divalent cations not necessary to improve activity, activation by dCTP and inhibition by dTTP both show an absolute requirement for a divalent cation. Mg2+, Ca2+ and Mn2+ almost equally effective in promoting activation by dCTP, Cu2+, Zn2+, and Co2+ are ineffective
Ca2+
-
divalent cations not necessary to improve activity, activation by dCTP and inhibition by dTTP both show an absolute requirement for a divalent cation. Mg2+, Ca2+ and Mn2+ almost equally effective in promoting activation by dCTP, Cu2+, Zn2+, and Co2+ are ineffective
Ca2+
-
activation of enzyme by dCTP or inhibition by TTP has absolute requirement for the presence of a divalent cation. Mg2+, Ca2+ and Mn2+ are equally effective cations for enzyme activation by dCTP, Mn2+ and Ca2+ are more effective than Mg2+ in enzyme inhibition by TTP
Mg2+
-
-
Mg2+
-
divalent cations not necessary to improve activity, activation by dCTP and inhibition by dTTP both show an absolute requirement for a divalent cation. Mg2+, Ca2+ and Mn2+ almost equally effective in promoting activation by dCTP, Cu2+, Zn2+, and Co2+ are ineffective
Mg2+
-
required for activation by dCTP and for inhibition by dTTP
Mg2+
-
activation of enzyme by dCTP or inhibition by TTP has absolute requirement for the presence of a divalent cation. Mg2+, Ca2+ and Mn2+ are equally effective cations for enzyme activation by dCTP, Mn2+ and Ca2+ are more effective than Mg2+ in enzyme inhibition by TTP
Mg2+
-
required for activation by dCTP, Mg2+ in the absence of dCTP: no effect
Mn2+
-
divalent cations not necessary to improve activity, activation by dCTP and inhibition by dTTP both show an absolute requirement for a divalent cation. Mg2+, Ca2+ and Mn2+ almost equally effective in promoting activation by dCTP, Cu2+, Zn2+, and Co2+ are ineffective
Mn2+
-
activation of enzyme by dCTP or inhibition by TTP has absolute requirement for the presence of a divalent cation. Mg2+, Ca2+ and Mn2+ are equally effective cations for enzyme activation by dCTP, Mn2+ and Ca2+ are more effective than Mg2+ in enzyme inhibition by TTP
additional information
-
metal ions not required
additional information
-
no metals required
additional information
-
divalent cations not necessary to improve activity, activation by dCTP and inhibition by dTTP both show an absolute requirement for a divalent cation. Mg2+, Ca2+ and Mn2+ almost equally effective in promoting activation by dCTP, Cu2+, Zn2+, and Co2+ are ineffective
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2',2'-difluoro-dCTP
-
dual mechanism of inhibition; partial purified enzyme
2',2'-difluorodeoxycytidine
-
high cellular nucleotide levels: inhibition: Concentration-dependent inhibition; inhibition by nucleotides of 2',2'-difluorodeoxycytidine, dual mechanism of inhibition
2',3'-dihydro-2',3'-dideoxy-thymidine monophosphate
-
-
2'-beta-D-deoxyribose-pyrimidin-2-one 5'-phosphate
-
competitive inhibition, Ki: 0.000012 mM
2'-deoxythymidine
-
0.05 mM: 60% inhibition, 0.01 mM: 5% inhibition; dThd
3'-azido-2',3'-dideoxy-thymidine monophosphate
-
-
3,4,5,6-tetrahydro-2'-deoxyuridine
-
specifc inhibition
3,4,5,6-tetrahydro-2'-dUMP
5-(acryloylamino-pentanol-1)2'-beta-D-dUMP
-
-
5-Hg-dCMP
-
potent inhibitor, in the absence of 2-mercaptoethanol, 0.00024 mM: 37% inhibition, 0.0024 mM: 70% inhibition
5-Hg-dUMP
-
potent inhibitor, 0.0001 mM: 54% inhibition
AMP
-
slight inhibition, competitive inhibitor, mechanism of inhibition
arabinosylcytosine
-
ara-C, deactivating dCMP deaminase
beta-D-2',2'-difluorodeoxycytidine
-
competitive
beta-L-2',3'-dideoxy-3'-thiacytidine monophosphate
-
slight inhibition
beta-L-2',3'-dideoxy-5'-fluoro-3'-thiacytidine monophosphate
-
-
Co2+
-
1 mM: 75% inhibition
Cu2+
-
1 mM: 98% inhibition
D-beta-2'-fluoro-5-methyl-arabinofuranosyluracil monophosphate
-
no inhibition by L-beta-2'-fluoro-5-methyl-arabinofuranosyluracil monophosphate
dCTP
-
allosteric activator, 12fold, for aminohydrolysis of dCMP, inhibitor, 50% inhibition, for substrate: 5-Hg-dCMP in the presence of mercaptoethanol, dCMP-Hg-S-CH2-CH2-OH
deoxytetrahydrouridine
-
-
EDTA
-
no inhibition by EDTA
Hg(CH3COO)2
-
Hg(acetate)2; mercuroacetate, potent inhibitor, 0.0002 mM: 26% inhibition, 0.001 mM: 40% inhibition
TDP
-
slight inhibition, competitive inhibitor, mechanism of inhibition
tetrahydrodeoxyuridine
-
-
Zn2+
-
1 mM: 94% inhibition
3,4,5,6-tetrahydro-2'-dUMP
-
specific potent inhibitor
3,4,5,6-tetrahydro-2'-dUMP
-
potent inhibitor, Ki: 0.00001 mM
dGMP
-
effective competitive inhibitor, mechanism of inhibition
dGMP
-
potent competitive inhibitor
dTTP
-
allosteric inhibitor
dTTP
-
0.0015 mM: 50% inhibition. dTTP inhibition reversed by dCTP; allosteric inhibitor
dTTP
-
allosteric inhibitor
dTTP
-
inhibits dCMPD by allosteric interaction
dUMP
-
poor competitive inhibitor, mechanism of inhibition
dUMP
-
product inhibition
dUMP
-
potent competitive inhibitor
dUTP
-
slight inhibition
GMP
-
slight inhibition
GMP
-
potent competitive inhibitor
TMP
-
poor competitive inhibitor, mechanism of inhibition
TTP
-
activating enzyme up to 1.7fold at concentration of 0.00025 mM, but inhibiting at higher concentration, 0.015 mM: 85% inhibition; inhibition by TTP has absolute requirement for the presence of a divalent cation, Mn2+ and Ca2+ are more effective than Mg2+ in the inhibition of enzyme activity by TTP; TTP inhibition partially reversed by dCTP
TTP
-
inhibits dCMPD by allosteric interaction
additional information
-
no inhibition by EDTA
-
additional information
-
little or no inhibition by 3,4,5,6-tetrahydrouridine; mechanism of inhibition
-
additional information
-
no inhibition by deoxynucleotide triphosphates
-
additional information
-
inhibitory potency of pyrimidine phosphate analogues, overview
-
additional information
-
monophosphates of deoxycytidine analogs nucleosides in the L-conformation (e.g. apricitabine, lamivudine, and emtricitabine) and dideoxycytidine do not act as inhibitors of dCMPD
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Adenocarcinoma
Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer.
Adenocarcinoma
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy.
Aortic Valve Stenosis
Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.
Asthma
Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation.
Asthma
Expression and function of the ST2 gene in a murine model of allergic airway inflammation.
Asthma
ST2 expression and release by the bronchial epithelium is downregulated in asthma.
Autoimmune Diseases
Identification of human ST2 protein in the sera of patients with autoimmune diseases.
Brain Neoplasms
Sensitization to X ray by 5-chloro-2'-deoxycytidine co-administered with tetrahydrouridine in several mammalian cell lines and studies of 2'-chloro derivatives.
Breast Neoplasms
An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients.
Breast Neoplasms
Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products.
Carcinogenesis
Identification of novel cellular targets in biliary tract cancers using global gene expression technology.
Carcinoma, Ehrlich Tumor
Deoxycytidylate aminohydrolase in cells of Ehrlich ascites tumour.
Carcinoma, Hepatocellular
Activities of some enzymes of pyrimidine and DNA synthesis in a rat transplantable hepatoma and human primary hepatomas, in cell lines derived from these tissues, and in human fetal liver.
Carcinoma, Hepatocellular
Correlation of deoxycytidylate deaminase activity with cell proliferation during hepatocarcinogenesis and tumour growth in transplantable rat hepatomas.
Carcinoma, Hepatocellular
Deoxycytidylate deaminase and related enzymes of thymidine triphosphate metabolism in hepatomas and precancerous rat liver.
Carcinoma, Hepatocellular
Deoxycytidylate Deaminase and Thymine Catabolic Activity of Transplanted Mouse and Rat Hepatomas and their Histology.
Carcinoma, Hepatocellular
Factors affecting deoxycytidylate deaminase activity in some transplantable rat hepatomas.
Carcinoma, Hepatocellular
Nucleotide interconversions. IV. Activities of deoxycytidylate deaminase and thymidylate synthetase in normal rat liver and hepatomas.
Carcinoma, Hepatocellular
The comparative enzymology and cell origin of rat hepatomas. I. Deoxycytidylate deaminase and thymine degradation.
Cardiomyopathy, Dilated
Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.
Cysts
The influence of the nucleus on the regulation of the dCMP deaminase in acetabularia.
dcmp deaminase deficiency
Imbalanced deoxyribonucleoside triphosphate pools and spontaneous mutation rates determined during dCMP deaminase-defective bacteriophage T4 infections.
dcmp deaminase deficiency
Mutational specificity of DNA precursor pool imbalances in yeast arising from deoxycytidylate deaminase deficiency or treatment with thymidylate.
dcmp deaminase deficiency
Phage T4-induced dTTP accretion bolsters a tRNase-based host defense.
dcmp deaminase deficiency
Replication Fork Collapse and Genome Instability in dCMP Deaminase Mutant.
Dengue
Elevated levels of soluble ST2 protein in dengue virus infected patients.
Eclampsia
Serum deoxycytidylate deaminase as an index of high-risk pregnancy.
Essential Hypertension
Serum deoxycytidylate deaminase as an index of high-risk pregnancy.
Glioma
Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma.
Heart Diseases
ST2 protein in heart disease: from discovery to mechanisms and prognostic value.
Heart Failure
Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
Heart Failure
Soluble ST2 protein in chronic heart failure is independent of traditional factors.
Heart Failure, Systolic
Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure.
Herpes Simplex
Aanlysis of dCMP deaminase and CDP reductase levels in hamster cells infected by herpes simplex virus.
Herpes Simplex
Deoxycytidylate deaminase evidence for a new enzyme in cells infected by the virus of herpes simplex.
Herpes Simplex
The effect of 5-iodo-2'-deoxyuridine 5'-triphosphate, an allosteric inhibitor, on deoxycytidylate deaminase "induced" by herpes simplex virus.
Idiopathic Pulmonary Fibrosis
The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis.
Infections
Aanlysis of dCMP deaminase and CDP reductase levels in hamster cells infected by herpes simplex virus.
Infections
Relationship between Escherichia coli B titer and the level of deoxycytidylate deaminase activity induced on bacteriophage T2r + infection.
Leukemia
Deoxycytidylate deaminase activity in lymphoproliferative disorders.
Leukemia
Deoxycytidylate deaminase activity in non-stimulated and phytohemagglutinin-stimulated human lymphocytes, and in leukemic cells.
Leukemia
Kinetic behaviour and allosteric regulation of human deoxycytidylate deaminase derived from leukemic cells.
Leukemia
Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine.
Leukemia
Therapeutic response of leukemic mice treated with fluorinated pyrimidines and inhibitors of deoxyuridylate synthesis.
Leukemia, Lymphocytic, Chronic, B-Cell
Deoxycytidylate deaminase activity in non-stimulated and phytohemagglutinin-stimulated human lymphocytes, and in leukemic cells.
Leukemia, Monocytic, Acute
Deoxycytidylate deaminase activity in non-stimulated and phytohemagglutinin-stimulated human lymphocytes, and in leukemic cells.
Leukemia, Myeloid, Acute
Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase II? as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin.
Liver Neoplasms, Experimental
Deoxycytidylate aminohydrolase activity in the Novikoff hepatoma is dependent on the localization of the tumor.
Liver Neoplasms, Experimental
Factors affecting deoxycytidylate deaminase activity in some transplantable rat hepatomas.
Lung Injury
IL-1 R-related protein ST2 suppressed the initial stage of bleomycin-induced lung injury.
Lymphoma
Deoxycytidylate deaminase activity in lymphoproliferative disorders.
Lymphoma, Non-Hodgkin
Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine.
Lymphoproliferative Disorders
Deoxycytidylate deaminase activity in lymphoproliferative disorders.
Myocardial Infarction
Deoxycytidylate deaminase in the diagnosis of acute myocardial infarction.
Myocardial Infarction
Serum deoxycytidylate deaminase activity after myocardial infarction.
Nasal Polyps
[Expression and role of IL-33 and its receptor ST2 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps].
Neoplasms
Activation of deoxycytidylate deaminase from certain embryonal and tumour tissues by 6-aza-2'-deoxycytidine-5'-monophosphate and 2'-deoxycytidine-5'-triphosphate.
Neoplasms
Activities of various enzymes of pyrimidine nucleotide and DNA syntheses in normal and neoplastic human tissues.
Neoplasms
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.
Neoplasms
Correlation of deoxycytidylate deaminase activity with cell proliferation during hepatocarcinogenesis and tumour growth in transplantable rat hepatomas.
Neoplasms
Deoxycytidylate aminohydrolase activity in the Novikoff hepatoma is dependent on the localization of the tumor.
Neoplasms
Deoxycytidylate aminohydrolase in cells of Ehrlich ascites tumour.
Neoplasms
Deoxycytidylate deaminase activity in lymphoproliferative disorders.
Neoplasms
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction.
Neoplasms
Effect of Magnesium Supplementation on Circulating Biomarkers of Cardiovascular Disease.
Neoplasms
Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic.
Neoplasms
Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer, effectively controls five advanced human tumors in nude mice.
Neoplasms
Identification of novel cellular targets in biliary tract cancers using global gene expression technology.
Neoplasms
In vitro and in vivo radiation sensitization by the halogenated pyrimidine 5-chloro-2'-deoxycytidine.
Neoplasms
INCREASED STABILITY OF TEMPLATES FOR SOME ENZYMES OF DNA SYNTHESIS IN TUMORS: DEOXYCYTIDYLATE DEAMINASE, THYMIDINE AND THYMIDYLATE KINASE.
Neoplasms
Metabolism of pyrimidine nucleotides in various tissues and tumor cells from rodents.
Neoplasms
Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine.
Neoplasms
Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
Neoplasms
Sensitization to X ray by 5-chloro-2'-deoxycytidine co-administered with tetrahydrouridine in several mammalian cell lines and studies of 2'-chloro derivatives.
Neoplasms
The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G.
Neoplasms
Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Neoplasms
Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
Nephrotic Syndrome
Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation.
Non-ST Elevated Myocardial Infarction
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction.
Pancreatic Neoplasms
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy.
Placental Insufficiency
Serum deoxycytidylate deaminase as an index of high-risk pregnancy.
Pleural Effusion, Malignant
Expression of ST2 in helper T lymphocytes of malignant pleural effusions.
Pneumonia
ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation.
Pre-Eclampsia
Plasma urate and serum deoxycytidylate deaminase measurements for the early diagnosis of pre-eclampsia.
Pre-Eclampsia
Serum deoxycytidylate deaminase as an index of high-risk pregnancy.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Deoxycytidylate deaminase activity in non-stimulated and phytohemagglutinin-stimulated human lymphocytes, and in leukemic cells.
Pregnancy, High-Risk
Serum deoxycytidylate deaminase as an index of high-risk pregnancy.
Sarcoma, Avian
Induction of deoxycytidylate deaminase and uridine kinase and activation of cellular DNA synthesis in the course of transformation of chicken embryo cells infected by Rous sarcoma virus in vitro.
Sepsis
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma.
ST Elevation Myocardial Infarction
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction.
Stomach Neoplasms
Decreased ST2 expression is associated with gastric cancer progression and pathogenesis.
Subarachnoid Hemorrhage
Elevation of ST2 protein levels in cerebrospinal fluid following subarachnoid hemorrhage.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Ellims, P.H.; Kao, A.Y.; Chabner, B.A.
Deoxycytidylate deaminase. Purification and some properties of the enzyme isolated from human spleen
J. Biol. Chem.
256
6335-6340
1981
Homo sapiens
brenda
Xu, Y.Z.; Plunkett, W.
Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine
Biochem. Pharmacol.
44
1819-1827
1992
Homo sapiens
brenda
Moore, J.T.; Ciesla, J.M.; Changchien, L.M.; Maley, G.F.; Maley, F.
Identification of a site necessary for allosteric regulation in T4-phage deoxycytidylate deaminase
Biochemistry
33
2104-2112
1994
Tequatrovirus T4, Homo sapiens
brenda
Maley, G.F.; Lobo, A.P.; Maley, F.
Properties of an affinity-column-purified human deoxycytidylate deaminase
Biochim. Biophys. Acta
1162
161-170
1993
Homo sapiens
brenda
Riva, C.M.; Barra, Y.; Cano, J.P.; Tubiana, N.; Lejeune, C.; Merlin, M.; de Sousa, G.; Carcassonne, Y.; Kreis, W.; Lovecchio, J.; Rottachi, C.; Rustum, Y.M.
Correlation between deoxycytidine kinase and deaminase activities and response to therapy with ARA-C
J. Cell. Pharmacol.
1
79-85
1990
Homo sapiens
-
brenda
Maley, F.; Maley, G.F.
A tale of two enzymes, deoxycytidylate deaminase and thymidylate synthase
Prog. Nucleic Acid Res. Mol. Biol.
39
49-80
1990
Bacillus subtilis, Betapolyomavirus macacae, Echinoidea, Enterobacteria phage T6, Equus asinus, Escherichia phage T2, Gallus gallus, Herpes simplex virus, Homo sapiens, no activity in Escherichia coli, no activity in Salmonella typhimurium, Polyomavirus sp., Rattus norvegicus, Saccharomyces cerevisiae, Tequatrovirus T4
brenda
Jost, J.P.; Thiry, S.; Siegmann, M.
5-Methyldeoxycytidine monophosphate deaminase and 5-methylcytidyl-DNA deaminase activities are present in human mature sperm cells
FEBS Lett.
519
128-134
2002
Homo sapiens
brenda
Gribaudo, G.; Riera, L.; Caposio, P.; Maley, F.; Landolfo, S.
Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells
J. Gen. Virol.
84
1437-1441
2003
Homo sapiens
brenda
Liou, J.Y.; Krishnan, P.; Hsieh, C.C.; Dutschman, G.E.; Cheng, Y.C.
Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase
Mol. Pharmacol.
63
105-110
2003
Homo sapiens
brenda
Li, L.S.; Morales, J.C.; Veigl, M.; Sedwick, D.; Greer, S.; Meyers, M.; Wagner, M.; Fishel, R.; Boothman, D.A.
DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets
Br. J. Pharmacol.
158
679-692
2009
Homo sapiens
brenda
Jansen, R.S.; Rosing, H.; Schellens, J.H.; Beijnen, J.H.
Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites?
Fundam. Clin. Pharmacol.
25
172-185
2011
Homo sapiens
brenda